Year All20232022202120202019201820172016 September 6, 2023 Apollomics to Present at the H.C. Wainwright 25th Annual Global Investment Conference April 11, 2023 Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium March 30, 2023 Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
September 6, 2023 Apollomics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
April 11, 2023 Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium
March 30, 2023 Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq